NCT04940923

Brief Summary

Whiplash describes an injury to the neck caused by a rapid movement of the head. It often occurs during a motor vehicle collision, causing considerable pain and distress. Most patients are diagnosed with whiplash associated disorder grade-2 (WAD2). Half of these patients develop chronic pain. Current treatments for patients are ineffective. It is difficult to predict which patients will develop chronic pain, and therefore how to manage these patients. The characteristics of pain felt by many patients with WAD2 suggests that symptoms are caused by an injury to the nerves in the neck and arm. However, on clinical examination there is no indication that these nerves are significantly injured. Work from the investigators' laboratory suggests that nerves may be inflamed. In this study, the contribution of nerve inflammation to symptoms early following whiplash will be established. It will determine whether clinical tests are able to identify those patients with inflamed nerves. It will also determine whether the presence of nerve inflammation can be used to identify patients who develop chronic pain. The study will recruit 115 patients within one month following a whiplash injury and thirty-two healthy volunteers. Participants will undergo a clinical assessment. A blood sample will be taken to look for inflammatory proteins and magnetic resonance imaging will be used to identify nerve inflammation in the neck and wrist. Questionnaires to establish neck disability, pain quality and psychological distress will be completed. MRI findings will be compared to healthy controls. At six-months, patients will be asked to repeat the questionnaires, which will be used to identify those patients who have recovered. Twenty-five recovered and twenty-five non-recovered patients will undergo a repeat MRI and clinical assessment. Although patients on this study will not directly benefit, the findings will help with early diagnosis and could refocus treatment to reduce chronic pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
147

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

June 9, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

1.7 years

First QC Date

June 9, 2021

Last Update Submit

November 3, 2022

Conditions

Keywords

Magnetic resonance imagingPain thresholdNeuritisPrognosis

Outcome Measures

Primary Outcomes (4)

  • MRI T2-weighted nerve signal strength

    T2-weighted nerve signal strength in the brachial plexus and median nerve compared to healthy control group

    Baseline

  • Change in MRI T2-weighted nerve signal strength

    Change in T2-weighted nerve signal strength in the brachial plexus and median nerve at 6 months compared to baseline

    From baseline to 6 months

  • Fractional anisotropy from diffusion tensor images

    Fractional anisotropy measurements from brachial plexus and median nerve compared to healthy controls

    Baseline

  • Change in fractional anisotropy from Diffusion tensor images

    Fractional anisotropy from brachial plexus and median nerve compared to baseline

    From baseline to 6 months

Secondary Outcomes (18)

  • T1 MRI median nerve morphology

    Baseline

  • Changes to T1 MRI median nerve morphology

    From baseline to 6 months

  • Pro-inflammatory cytokine levels

    Baseline

  • Change in Pro-inflammatory cytokine levels

    From baseline to 6 months

  • Tests for heightened nerve mechanosensitivity- upper limb neurodynamic test (median nerve)

    Baseline

  • +13 more secondary outcomes

Study Arms (2)

Patients

Patients within 4 weeks of a whiplash injury.

Diagnostic Test: MRI

Healthy controls

Age and gender matched healthy controls

Diagnostic Test: MRI

Interventions

MRIDIAGNOSTIC_TEST

T2 weighted and DTI MRI images of brachial plexus and wrist. Quantitative sensory tests include warm and cold detection and pain thresholds, paradoxical heat sensation, mechanical detection thresholds, mechanical pain sensation and thresholds, wind up ratios, vibration thresholds and pressure pain thresholds. Clinical tests include standard neurological tests and test for heightened nerve mechanosensitivity. Blood serum to analyse inflammatory proteins. Questionnaires include neck disability index, painDETECT, PTSD8, pain catastrophising scale, eq-5D-5L, DASS 42 and global perceived recovery

Also known as: Quantitative sensory tests, Blood serum tests, Clinical tests, Questionnaires
Healthy controlsPatients

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

People who have sustained a whiplash injury less than 4 weeks prior to their participation in the study. Healthy volunteers.

You may qualify if:

  • Patients:
  • Male and female patients with chronic whiplash associated disorder that meet the Quebec Task Force Classification of whiplash grade II
  • Within approximately four weeks of their whiplash injury
  • Age 18-60
  • Participants capable of giving informed consent
  • Healthy Volunteers:
  • Free of neck or upper limb pain
  • No history of a whiplash injury or of neck or arm pain lasting \>3 months or any recent cervical or upper limb trauma requiring medical treatment.
  • Age 18-60
  • Participants capable of giving informed consent

You may not qualify if:

  • Patients:
  • Diagnosis of whiplash grade I (neck complaints without physical signs), III (obvious neurological signs) or IV (fracture or dislocation)
  • Experienced concussion or loss of consciousness as a result of the accident
  • Previous history of whiplash
  • Previous history of neck pain or headaches that required treatment
  • All participants (patients and healthy volunteers):
  • Unsuitability to undergo MRI (assessed with the MRI screening questionnaire)
  • Pregnant
  • History of inflammatory disease (e.g. autoimmune diseases, rheumatoid arthritis), neuropathy, diabetes, cancer or non-medically controlled hypertension
  • Current ongoing steroid treatment
  • Participants with an inadequate understanding of English will also be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brighton and Sussex Medical School

Brighton, East Sussex, BN1 9RY, United Kingdom

RECRUITING

Oxford Neuroscience, University of Oxford

Oxford, Oxfordshire, OX3 9DU, United Kingdom

RECRUITING

Related Publications (3)

  • Ridehalgh C, Fundaun J, Bremner S, Cercignani M, Koushesh S, Schmid AB, Dilley A. Temporal development of peripheral neuroinflammation in whiplash-associated disorder grade II and its role in chronicity. Pain. 2026 Feb 1;167(2):356-371. doi: 10.1097/j.pain.0000000000003816. Epub 2025 Oct 10.

  • Ridehalgh C, Fundaun J, Bremner S, Cercignani M, Koushesh S, Young R, Novak A, Greening J, Schmid AB, Dilley A. Evidence for peripheral neuroinflammation after acute whiplash. Pain. 2025 Oct 1;166(10):2285-2299. doi: 10.1097/j.pain.0000000000003560. Epub 2025 Mar 4.

  • Ridehalgh C, Fundaun J, Bremner S, Cercignani M, Young R, Trivedy C, Novak A, Greening J, Schmid A, Dilley A. Does peripheral neuroinflammation predict chronicity following whiplash injury? Protocol for a prospective cohort study. BMJ Open. 2022 Dec 15;12(12):e066021. doi: 10.1136/bmjopen-2022-066021.

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood and serum

MeSH Terms

Conditions

Whiplash InjuriesNeuritis

Condition Hierarchy (Ancestors)

Neck InjuriesWounds and InjuriesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Andrew Dilley, PhD

    Brighton and Sussex Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrew Dilley, PhD

CONTACT

Colette Ridehalgh, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 28, 2021

Study Start

June 1, 2021

Primary Completion

March 1, 2023

Study Completion

April 1, 2024

Last Updated

November 4, 2022

Record last verified: 2022-11

Locations